Corrigendum: Brg-1 targeting of novel miR550a-5p/RNF43/Wnt signaling axis regulates colorectal cancer metastasis (Oncogene (2016) 35 (651-661) DOI: 10.1038/onc.2015.124);Brg-1 targeting of novel miR550a-5p/RNF43/Wnt signaling axis regulates colorectal cancer metastasis

Oncogene

Volumn 35, Issue 5, 2016, Pages 651-661

  Wang, G ^a   Fu, Y ^a   Yang, X ^a   Luo, X ^a   Wang, J ^a   Gong, J ^b   Hu, J ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BRG 1 PROTEIN; MICRORNA; MICRORNA 550A; PROTEIN; RING FINGER 43; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; DNA HELICASE; NUCLEAR PROTEIN; ONCOPROTEIN; RNF43 PROTEIN, HUMAN; SMARCA4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE IDENTIFICATION; GENE SILENCING; HIGH THROUGHPUT SEQUENCING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; MALE; METASTATIC COLORECTAL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RNA SEQUENCE; WNT SIGNALING PATHWAY; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CACO 2 CELL LINE; CELL MOTION; COLORECTAL TUMOR; GENETIC TRANSFECTION; GENETICS; HCT116 CELL LINE; HT 29 CELL LINE; METABOLISM; METASTASIS; MIDDLE AGED; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; XENOGRAFT;

ANIMALS; CACO-2 CELLS; CELL MOVEMENT; COLORECTAL NEOPLASMS; DNA HELICASES; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HCT116 CELLS; HETEROGRAFTS; HT29 CELLS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSFECTION; WNT SIGNALING PATHWAY;

EID: 84957441481     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2017.317     Document Type: Erratum

References (45)

1. Whitehouse I, Flaus A, Cairns BR, White MF, Workman JL, Owen-Hughes T. Nucleosome mobilization catalysed by the yeast SWI/SNF complex. Nature 1999; 400: 784-787.
2. Wilson BG, Roberts CW. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 2011; 11: 481-492.
3. Ramirez-Carrozzi VR, Nazarian AA, Li CC, Gore SL, Sridharan R, Imbalzano AN et al. Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response. Genes Dev 2006; 20: 282-296.
4. Han D, Jeon S, Sohn DH, Lee C, Ahn S, Kim WK et al. SRG3, a core component of mouse SWI/SNF complex, is essential for extra-embryonic vascular development. Dev Biol 2008; 315: 136-146.
5. Martens JA, Winston F. Recent advances in understanding chromatin remodeling by Swi/Snf complexes. Curr Opin Genet Dev 2003; 13: 136-142.
6. Sudarsanam P, Winston F. The Swi/Snf family nucleosome-remodeling complexes and transcriptional control. Trends Genet 2000; 16: 345-351.
7. Reisman D, Glaros S, Thompson EA. The SWI/SNF complex and cancer. Oncogene 2009; 28: 1653-1668.
8. Klochendler-Yeivin A, Muchardt C, Yaniv M. SWI/SNF chromatin remodeling and cancer. Curr Opin Genet Dev 2002; 12: 73-79.
9. Khavari PA, Peterson CL, Tamkun JW, Mendel DB, Crabtree GR. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 1993; 366: 170-174.
10. Griffin CT, Brennan J, Magnuson T. The chromatin-remodeling enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular development. Development 2008; 135: 493-500.
11. Wong AK, Shanahan F, Chen Y, Lian L, Ha P, Hendricks K et al. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 2000; 60: 6171-6177.
12. Valdman A, Nordenskjold A, Fang X, Naito A, Al-Shukri S, Larsson C et al. Mutation analysis of the BRG1 gene in prostate cancer clinical samples. Int J Oncol 2003; 22: 1003-1007.
13. Medina PP, Romero OA, Kohno T, Montuenga LM, Pio R, Yokota J et al. Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines. Hum Mutat 2008; 29: 617-622.
14. Bultman SJ, Herschkowitz JI, Godfrey V, Gebuhr TC, Yaniv M, Perou CM et al. Characterization of mammary tumors from Brg1 heterozygous mice. Oncogene 2008; 27: 460-468.
15. Sentani K, Oue N, Kondo H, Kuraoka K, Motoshita J, Ito R et al. Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas. Pathobiology 2001; 69: 315-320.
16. Sun A, Tawfik O, Gayed B, Thrasher JB, Hoestje S, Li C et al. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. Prostate 2007; 67: 203-213.
17. Lin H, Wong RP, Martinka M, Li G. BRG1 expression is increased in human cutaneous melanoma. Br J Dermatol 2010; 163: 502-510.
18. Koo BK, Spit M, Jordens I, Low TY, Stange DE, van de Wetering M et al. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature 2012; 488: 665-669.
19. Zou Y, Wang F, Liu FY, Huang MZ, Li W, Yuan XQ et al. RNF43 mutations are recurrent in Chinese patients with mucinous ovarian carcinoma but absent in other subtypes of ovarian cancer. Gene 2013; 531: 112-116.
20. Jiang X, Hao HX, Growney JD, Woolfenden S, Bottiglio C, Ng N et al. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci USA 2013; 110: 12649-12654.
21. Sugiura T, Yamaguchi A, Miyamoto K. A cancer-associated RING finger protein, RNF43, is a ubiquitin ligase that interacts with a nuclear protein, HAP95. Exp Cell Res 2008; 314: 1519-1528.
22. Zebisch M, Xu Y, Krastev C, MacDonald BT, Chen M, Gilbert RJ et al. Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin. Nat Commun 2013; 4: 2787.
23. McNutt NS, Mak LL, Kim YS. Comparison of cell peripheries in the human colonic adenocarcinoma cell lines SW480 and SW620 grown in floating chamber culture, cover slip culture, athymic (nude) mice, and BALB/c mice. Lab Invest 1981; 44: 309-323.
24. Stragand JJ, Bergerat JP, White RA, Hokanson J, Drewinko B. Biological and cell kinetic properties of a human colonic adenocarcinoma (LoVo) grown in athymic mice. Cancer Res 1980; 40: 2846-2852.
25. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003; 3: 362-374.
26. Koizumi Y, Tanaka S, Mou R, Koganei H, Kokawa A, Kitamura R et al. Changes in DNA copy number in primary gastric carcinomas by comparative genomic hybridization. Clin Cancer Res 1997; 3: 1067-1076.
27. Yen CC, Chen YJ, Lu KH, Hsia JY, Chen JT, Hu CP et al. Genotypic analysis of esophageal squamous cell carcinoma by molecular cytogenetics and real-time quantitative polymerase chain reaction. Int J Oncol 2003; 23: 871-881.
28. Katoh H, Shibata T, Kokubu A, Ojima H, Loukopoulos P, Kanai Y et al. Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome. J Hepatol 2005; 43: 863-874.
29. Tian Q, Liang L, Ding J, Zha R, Shi H, Wang Q et al. MicroRNA-550a acts as a pro-metastatic gene and directly targets cytoplasmic polyadenylation element-binding protein 4 in hepatocellular carcinoma. PLoS One 2012; 7: e48958.
30. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T et al. The colorectal microRNAome. Proc Natl Acad Sci USA 2006; 103: 3687-3692.
31. Shinada K, Tsukiyama T, Sho T, Okumura F, Asaka M, Hatakeyama S. RNF43 interacts with NEDL1 and regulates p53-mediated transcription. Biochem Biophys Res Commun 2011; 404: 143-147.
32. Anson M, Crain-Denoyelle AM, Baud V, Chereau F, Gougelet A, Terris B et al. Oncogenic beta-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. J Clin Invest 2012; 122: 586-599.
33. Sanchez-Tillo E, de Barrios O, Siles L, Cuatrecasas M, Castells A, Postigo A. beta-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci USA 2011; 108: 19204-19209.
34. Valenta T, Hausmann G, Basler K. The many faces and functions of beta-catenin. EMBO J 2012; 31: 2714-2736.
35. Bai J, Mei P, Zhang C, Chen F, Li C, Pan Z et al. BRG1 is a prognostic marker and potential therapeutic target in human breast cancer. PLoS One 2013; 8: e59772.
36. Trotter KW, Archer TK. The BRG1 transcriptional coregulator. Nuclear Receptor Signal 2008; 6: e004.
37. Xu Y, Zhang J, Chen X. The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF chromatin remodeling complexes. J Biol Chem 2007; 282: 37429-37435.
38. Dai Y, Ngo D, Jacob J, Forman LW, Faller DV. Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes. Carcinogenesis 2008; 29: 1725-1733.
39. Liu K, Luo Y, Lin FT, Lin WC. TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival. Genes Dev 2004; 18: 673-686.
40. Van Rechem C, Boulay G, Leprince D. HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A. Biochem Biophys Res Commun 2009; 385: 586-590.
41. Marignani PA, Kanai F, Carpenter CL. LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest. J Biol Chem 2001; 276: 32415-32418.
42. von Figura G, Fukuda A, Roy N, Liku ME, Morris Iv JP, Kim GE et al. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. Nat Cell Biol 2014; 16: 255-267.
43. Wang G, Chen C, Yang R, Cao X, Lai S, Luo X et al. p55PIK-PI3K stimulates angiogenesis in colorectal cancer cell by activating NF-kappaB pathway. Angiogenesis 2013; 16: 561-573.
44. Wang G, Cao X, Lai S, Luo X, Feng Y, Wu J et al. Altered p53 regulation of miR-148b and p55PIK contributes to tumor progression in colorectal cancer. Oncogene 2014; 34: 912-921.
45. Wang G, Deng Y, Cao X, Lai S, Tong Y, Luo X et al. Blocking p55PIK signaling inhibits proliferation and induces differentiation of leukemia cells. Cell Death Differ 2012; 19: 1870-1879.